Histopathological, Immunohistochemical, Molecular and Genetic Biomarkers in Differentiated Thyroid Cancer
Cancers · 31.08.2025 · 17 (17) · 2869
DOI: 10.3390/cancers17172869 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cancers, online erschienen am 31.08.2025. Verfasst von Mousa A Al-Abbadi und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Histopathology, Microbiology and Forensic Medicine, School of Medicine, University of Jordan, Amman 11942, Jordan. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 125 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Differentiated thyroid cancer (DTC) is the most prevalent endocrine malignancy in the world. Accurate diagnosis and prognostication are essential for optimizing its treatment and improving patient outcomes. This narrative review explores the diagnostic and prognostic histopathological, immunohistochemical, molecular, and genetic biomarkers in DTC, emphasizing their role in risk stratification and personalized management. Histopathological biomarkers, including tumor size, extrathyroidal extension, lymphovascular invasion, and aggressive subtypes (e.g., tall cell, hobnail, and insular variants), correlate with poor prognosis. Additionally, genetic alterations such as BRAF:p.V600E, RAS mutations, TERT promoter mutations, and RET/PTC rearrangements provide molecular insights into tumor progression and therapeutic response. Some of these molecular/genetic mutations have surrogate proteins that are feasible for immunohistochemical analysis, providing faster and cost-effective alternatives. Advances in next-generation sequencing have further refined risk stratification, facilitating precision medicine approaches. Future research should focus on validating novel biomarkers and developing targeted therapies to improve patient outcomes.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Histopathology, Microbiology and Forensic Medicine, School of Medicine, University of Jordan, Amman 11942, Jordan.
- School of Medicine, University of Jordan, Amman 11942, Jordan.
- Division of Pathology and Laboratory Medicine, Phoenix Children's Hospital, Phoenix, AZ 85016, USA.
- Department of Child Health, College of Medicine, University of Arizona, Phoenix, AZ 85004, USA.
- Department of Radiology and Nuclear Medicine, School of Medicine, University of Jordan, Amman 11942, Jordan.
- Department of General Surgery, Jordan University Hospital, Amman 11942, Jordan.
ORCID-Profile: Dunia Aburizeg, Husam Abuawad, Hala Alzaghloul, Tala Qudisat
Zitieren
APA
Al-Abbadi, M. A., Aburizeg, D., Abuawad, H., Alzaghloul, H., Sqour, O., Azab, B., Qudisat, T., Alabbadi, A. M., Mismar, A., & Juweid, M. E. (2025). Histopathological, Immunohistochemical, Molecular and Genetic Biomarkers in Differentiated Thyroid Cancer. Cancers, 17(17), 2869. https://doi.org/10.3390/cancers17172869
Vancouver
Al-Abbadi MA, Aburizeg D, Abuawad H, Alzaghloul H, Sqour O, Azab B, et al. Histopathological, Immunohistochemical, Molecular and Genetic Biomarkers in Differentiated Thyroid Cancer. Cancers. 2025;17(17):2869. doi:10.3390/cancers17172869
BibTeX
@article{AlAbbadi2025,
author = {Al-Abbadi, Mousa A and Aburizeg, Dunia and Abuawad, Husam and Alzaghloul, Hala and Sqour, Omar and Azab, Bilal and Qudisat, Tala and Alabbadi, Ali M and Mismar, Ayman and Juweid, Malik Eid},
title = {Histopathological, Immunohistochemical, Molecular and Genetic Biomarkers in Differentiated Thyroid Cancer},
journal = {Cancers},
year = {2025},
volume = {17},
number = {17},
pages = {2869},
doi = {10.3390/cancers17172869}
}
EUVIMED